The ins and outs of iron homeostasis

Physiology

Volumn 21, Issue 2, 2006, Pages 115-123

  Donovan, Adriana ^a   Roy, Cindy N ^a   Andrews, Nancy C ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CATION TRANSPORT PROTEIN; HEPCIDIN; IRON; IRON REGULATORY FACTOR; METAL TRANSPORTING PROTEIN 1;

ANIMAL; HOMEOSTASIS; HUMAN; INTESTINE; IRON METABOLISM DISORDER; IRON OVERLOAD; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; HOMEOSTASIS; HUMANS; INTESTINES; IRON; IRON METABOLISM DISORDERS; IRON OVERLOAD; IRON-REGULATORY PROTEINS;

EID: 33646727321     PISSN: 15489213     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiol.00052.2005     Document Type: Review

References (107)

1. Abboud S and Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275: 19906-19912, 2000.
2. Adamsky K, Weizer O, Amariglio N, Breda L, Harmelin A, Rivella S, Rachmilewitz E, and Rechavi G. Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 124: 123-124, 2004.
3. Ahmad KA, Ahmann JR, Migas MC, Waheed A, Britton RS, Bacon BR, Sly WS, and Fleming RE. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 29: 361-366, 2002.
4. Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, and Koeller DM. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 8: 743-749, 1999.
5. Bannerman RM and Cooper RG. Sex-linked anemia: a hypochromic anemia of mice. Science 151: 581-582, 1966.
6. Bernstein SE. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J Lab Clin Med 110: 690-705, 1987.
7. Beutler E, Gelbart T, Lee P, Trevino R, Fernandez MA, and Fairbanks VF. Molecular characterization of a case of atransferrinemia. Blood 96: 4071-4074, 2000.
8. Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, Aminoff D, and Montreuil J. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 80: 173-195, 1998.
9. Breuer W, Hershko C, and Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 23: 185-192, 2000.
10. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, and Ram GA. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361: 669-673, 2003.
11. Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, and Arosio P. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 101: 1996-2000, 2003.
12. Childs S, Weinstein BM, Mohideen MA, Donohue S, Bonkovsky H, and Fishman MC. Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria. Curr Biol 10: 1001-1004, 2000.
13. Connor J, Pak CC, and Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 269: 2399-2404, 1994.
14. Cox TC, Bawden MJ, Martin A, and May BK. Human erythroid 5'-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J 10: 1891, 1991.
15. Cox TC, Bottomley SS, Wiley JS, Bawden MJ, Matthews CS, and May BK. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase [see comments]. N Engl J Med 330: 675-679, 1994.
16. Dailey HA. Terminal steps of haem biosynthesis. Biochem Soc Trans 30: 590-595, 2002.
17. Dandekar T, Stripecke R, Gray NK, Goossen B, Constable A, Johansson HE, and Hentze MW. Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA. EMBO J 10: 1903-1909, 1991.
18. Dautry-Varsat A, Ciechanover A, and Lodish HF. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 80: 2258-2262, 1983.
19. De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, and Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA 102: 8955-8960, 2005.
20. Donovan A, Brownlie A, Dorschner MO, Zhou Y, Pratt SJ, Paw BH, Phillips RB, Thisse C, Thisse B, and Zon LI. The zebrafish mutant gene chardonnay (cdy) encodes divalent metal transporter 1 (DMT1). Blood 100: 4655-4659, 2002.
21. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, and Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781, 2000.
22. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, and Andrews NC. The iron exporter ferroportin (Slc40a1) is essential for iron homeostasis. Cell Metabolism 1: 191-200, 2005.
23. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13: 399-408, 1996.
24. Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol 39: 270-281, 2002.
25. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, and Andrews NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 95: 1148-1153, 1998.
26. Fleming MD, Trenor CC, 3rd Su MA, Foernzler D, Beier DR, Dietrich WF, and Andrews NC. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16: 383-386, 1997.
27. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, and Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917-921.
28. Galbraith RA, Sassa S, and Kappas A. Heme binding to murine erythroleukemia cells. Evidence for a heme receptor. J Biol Chem 260: 12198-12202, 1985.
29. Gitlin D and Cruchaud A. On the kinetics of iron absorption in mice. J Clin Invest 41: 344-350, 1962.
30. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, and Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10: 1033-1043, 2002.
31. Gonzalez D, Drapier JC, and Bouton C. Endogenous nitration of iron regulatory protein-1 (IRP-1) in nitric oxide-producing murine macrophages: further insight into the mechanism of nitration in vivo and its impact on IRP-1 functions. J Biol Chem 279: 43345-43351, 2004.
32. Grasbeck R, Majuri R, Kouvonen I, and Tenhunen R. Spectral and other studies on the intestinal haem receptor of the pig. Biochim Biophys Acta 700: 137-142, 1982.
33. Gruenheid S, Cellier M, Vidal S, and Gros P. Identification and characterization of a second mouse Nramp gene. Genomics 25: 514-525, 1995.
34. Gunshin H, Fujiwara Y, Custodio AO, Direnzo C, Robine S, and Andrews NC. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest 115: 1258-1266, 2005.
35. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, and Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482-488, 1997.
36. Gunshin H, Starr CN, Direnzo C, Fleming MD, Jin J, Greer EL, Sellers VM, Galica SM, and Andrews NC. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood 106: 2879-2883, 2005.
37. Guo B, Phillips JD, Yu Y, and Leibold EA. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J Biol Chem 270: 21645-21651, 1995.
38. Haile DJ, Rouault TA, Tang CK, Chin J, Harford JB, and Klausner RD. Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster. Proc Natl Acad Sci USA 89: 7536-7540, 1992.
39. Hanson ES, Foot LM, and Leibold EA. Hypoxia post-translationally activates iron-regulatory protein 2. J Biol Chem 274: 5047-5052, 1999.
40. Harris ZL, Durley AP, Man TK, and Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 96: 10812-10817, 1999.
41. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, and Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92: 2539-2543, 1995.
42. Hentze MW and Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93: 8175-8182, 1996.
43. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, and Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest 115: 2187-2191, 2005.
44. Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, and Fleming MD. Identification of a novel mutation (C321X) in HJV. Blood 104: 2176-2177, 2004.
45. Hubert N and Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci USA 99: 12345-12350, 2002.
46. Iolascon A, d'Apolito M, Servedio V, Cimmino F, Piga A, and Camaschella C. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1. Blood 107: 349-354, 2006.
47. Iwai K, Klausner RD, and Rouault TA. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J 14: 5350-5357, 1995.
48. Jabado N, Canonne-Hergaux F, Gruenheid S, Picard V, and Gros P. Iron transporter Nramp2/DMT-1 is associated with the membrane of phagosomes in macrophages and Sertoli cells. Blood 100: 2617-2622, 2002.
49. Johnson MB and Enns CA. Regulation of transferrin receptor 2 by transferrin: diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104: 4287-4293, 2004.
50. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, and Koeffler HP. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105: 376-381, 2005.
51. Kawabata H, Nakamaki T, Ikonomi P, Smith RD, Germain RS, and Koeffler HP. Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. Blood 98: 2714-2719, 2001.
52. Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, and Koeffler HP. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 274: 20826-20832, 1999.
53. Kiefer CR and Snyder LM. Oxidation and erythrocyte senescence. Curr Opin Hematol 7: 113-116, 2000.
54. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, and Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480: 147-150, 2000.
55. Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S, Mercer KE, Sarkadi B, Sorrentino BP, and Schuetz JD. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279: 24218-24225, 2004.
56. Lam-Yuk-Tseung S, Touret N, Grinstein S, and Gros P. Carboxyl-terminus determinants of the iron transporter DMT1/SLC11A2 isoform II (-IRE/1B) mediate internalization from the plasma membrane into recycling endosomes. Biochemistry 44: 12149-12159, 2005.
57. Lang F, Lang KS, Wieder T, Myssina S, Birka C, Lang PA, Kaiser S, Kempe D, Duranton C, and Huber SM. Cation channels, cell volume and the death of an erythrocyte. Pflügers Arch 447: 121-125, 2003.
58. Levy JE, Jin O, Fujiwara Y, Kuo F, and Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 21: 396-399, 1999.
59. Lin L, Goldberg YP, and Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106: 2884-2889, 2005.
60. McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, and Simpson RJ. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291: 1755-1759, 2001.
61. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, and Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309, 2000.
62. Mims MP, Guan Y, Pospisilova D, Priwitzerova M, Indrak K, Ponka P, Divoky V, and Prchal JT. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 105: 1337-1342, 2005.
63. Mok H, Jelinek J, Pai S, Cattanach BM, Prchal JT, Youssoufian H, and Schumacher A. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development 131: 1859-1868, 2004.
64. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, and Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108: 619-623, 2001.
65. Muckenthaler M, Roy CN, Custodio AO, Minana B, deGraaf J, Montross LK, Andrews NC, and Hentze MW. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet 34: 102-107, 2003.
66. Muir A and Hopfer U. Regional specificity of iron uptake by small intestinal brush-border membranes from normal and iron-deficient mice. Am J Physiol Gastrointest Liver Pathol 248: G376-G379, 1985.
67. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276, 2004.
68. Nemeth E, Roetto A, Garozzo G, Ganz T, and Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 105: 1803-1806, 2005.
69. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004.
70. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, and Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98: 8780-8785, 2001.
71. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037-1044, 2002.
72. Niederkofler V, Salie R, and Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 115: 2180-2186, 2005.
73. +)-ATPases: nature's most versatile proton pumps. Nat Rev Mol Cell Biol 3: 94-103, 2002.
74. Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, van Duijn CM, and Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28: 213-214, 2001.
75. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE, and Fleming MD. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 37: 1264-1269, 2005.
76. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9: 1187-1194, 2003.
77. Pantopoulos K and Hentze MW. Activation of iron regulatory protein-1 by oxidative stress in vitro. Proc Natl Acad Sci USA 95: 10559-10563, 1998.
78. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, and Goldberg YP. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36: 77-82, 2004.
79. Park CH, Valore EV, Waring AJ, and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810, 2001.
80. Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med 350: 2383-2397, 2004.
81. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, and Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819, 2001.
82. Pinkerton PH. Histological evidence of disordered iron transport in the x-linked hypochromic anaemia of mice. J Pathol Bacteriol 95: 155-165, 1968.
83. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919-10924, 1997.
84. Quigley JG, Yang Z, Worthington MT, Phillips JD, Sabo KM, Sabath DE, Berg CL, Sassa S, Wood BL, and Abkowitz JL. Identification of a human heme exporter that is essential for erythropoiesis. Cell 118: 757-766, 2004.
85. Raffin SB, Woo CH, Roost KT, Price DC, and Schmid R. Intestinal absorption of hemoglobin iron-heme cleavage by mucosal heme oxygenase. J Clin Invest 54: 1344-1352, 1974.
86. Recalcati S, Taramelli D, Conte D, and Cairo G. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood 91: 1059-1066, 1998.
87. Robb A and Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104: 4294-4299, 2004.
88. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, and Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33: 21-22, 2003.
89. Rufenacht UB, Gouya L, Schneider-Yin X, Puy H, Schafer BW, Aquaron R, Nordmann Y, Minder EI, and Deybach JC. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 62: 1341-1352, 1998.
90. Schimanski LM, Drakesmith H, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, and Townsend AR. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105: 4096-4102, 2005.
91. Sellers VM, Dailey TA, and Dailey HA. Examination of ferrochelatase mutations that cause erythropoietic protoporphyria. Blood 91: 3980-3985, 1998.
92. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, and McKie AT. Identification of an intestinal heme transporter. Cell 122: 789-801, 2005.
93. Smith TG, Serghides L, Patel SN, Febbraio M, Silverstein RL, and Kain KC. CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum. Infect Immun 71: 393-400, 2003.
94. Theil EC. Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr 133: 1549-1553, 2003.
95. Torti FM and Torti SV. Regulation of ferritin genes and protein. Blood 99: 3505-3516, 2002.
96. 2+ channel modifiers: possible implications in iron overload. Circ Res 84: 1302-1309, 1999.
97. Tutois S, Montagutelli X, Da Silva V, Jouault H, Rouyer-Fessard P, Leroy-Viard K, Guenet JL, Nordmann Y, Beuzard Y, and Deybach JC. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. J Clin Invest 88: 1730-1736, 1991.
98. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, and Anderson GJ. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21: 195-199, 1999.
99. Wardrop SL and Richardson DR. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake. Eur J Biochem 263: 41-49, 1999.
100. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, and Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100: 3776-3781, 2002.
101. Weiss G, Bogdan C, and Hentze MW. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 158: 420-425, 1997.
102. Wingert RA, Brownlie A, Galloway JL, Dooley K, Fraenkel P, Axe JL, Davidson AJ, Barut B, Noriega L, Sheng X, Zhou Y, and Zon LI. The chianti zebrafish mutant provides a model for erythroid-specific disruption of transferrin receptor 1. Development 131: 6225-6235, 2004.
103. Worthington MT, Cohn SM, Miller SK, Luo RQ, and Berg CL. Characterization of a human plasma membrane heme transporter in intestinal and hepatocyte cell lines. Am J Physiol Gastrointest Liver Physiol 280: G1172-G1177, 2001.
104. Xu H, Jin J, DeFelice LJ, Andrews NC, and Clapham DE. A spontaneous, recurrent mutation in divalent metal transporter-1 exposes a calcium entry pathway. PLoS Biol 2: E50, 2004.
105. Yang F, Liu XB, Quinones M, Melby PC, Ghio A, and Haile DJ. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem 277: 39786-39791, 2002.
106. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, and Barasch J. An iron delivery pathway mediated by a lipocalin. Mol Cell 10: 1045-1056, 2002.
107. Zhang AS, Xiong S, Tsukamoto H, and Enns CA. Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood 103: 1509-1514, 2004.